Mimedx (MDXG) Cash from Operations Growth (1y) (2012 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | -12.60% |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn | -169.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -169.46% |
| Mar 31, 2026 | -64.54% |
| Dec 31, 2025 | 32.88% |
| Sep 30, 2025 | 49.45% |
| Jun 30, 2025 | -34.27% |
| Mar 31, 2025 | -21.90% |
| Dec 31, 2024 | 102.60% |
| Sep 30, 2024 | 49.81% |
| Jun 30, 2024 | 32.03% |
| Mar 31, 2024 | 267.61% |
| Dec 31, 2023 | 264.83% |
| Sep 30, 2023 | 1,266.01% |
| Jun 30, 2023 | 652.91% |
| Mar 31, 2023 | 60.40% |
| Dec 31, 2022 | 49.44% |
| Sep 30, 2022 | -84.85% |
| Jun 30, 2022 | -287.93% |
| Mar 31, 2022 | -53.06% |
| Dec 31, 2021 | -8.35% |
| Sep 30, 2021 | 237.07% |